In a groundbreaking clinical trial, a patient with a rare form of cancer is finding hope through TCR-T Cell Therapy. This innovative immunotherapy approach, conducted through a collaboration between Memorial Cancer Institute and Moffett Cancer Center, involves modifying the patient’s T-cells to target specific proteins in cancer cells. By harnessing the power of the body’s […]